{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:30:03Z","timestamp":1793806203600,"version":"4.6.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Protein S-palmitoylation regulates protein localization, stability, and signaling and has emerging roles in bone-cell biology. We investigated whether genetically predicted expression of palmitoylation-related genes is associated with osteoporosis risk and explored circulating metabolites as candidate mediators. We performed a 2-sample Mendelian randomization (MR) study using cis-expression quantitative trait locus instruments for 22 palmitoylation-related genes, FinnGen R10 osteoporosis data (8017 cases and 391,037 controls), and 1400 circulating metabolite traits (1091 metabolites and 309 metabolite ratios). Inverse-variance weighted was the primary estimator. Weighted-median and MR-Egger analyses, Cochran\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      testing, and instrument-strength assessment were used as sensitivity analyses. Summary-data-based MR with the heterogeneity in dependent instruments test was used as an additional gene expression validation. Gene Expression Omnibus bone marrow mesenchymal stem cell datasets were used for expression comparison; GSE35959 was treated as the SuperSeries containing GSE35956 and GSE35958 rather than as an independent replication cohort. Two-step MR and the product-of-coefficients approach were used to estimate candidate mediation effects. Genetically predicted zinc finger DHHC-type palmitoyltransferase 8 (ZDHHC8) expression was associated with higher osteoporosis risk (odds ratio\u2005=\u20051.23, 95% confidence interval: 1.09\u20131.39,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.0007), and the association met the Bonferroni threshold for the 22-gene screen. Summary-data-based MR provided additional, nominal evidence for ZDHHC8 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.0415). ZDHHC8 expression was higher in osteoporosis-derived bone marrow mesenchymal stem cells in the Gene Expression Omnibus comparison. Three metabolite traits: 3-(3-amino-3-carboxypropyl)uridine (acp3U), 2-hydroxyhippurate, and X-25343, showed directionally coherent 2-step MR estimates, with estimated mediated proportions of 11%, 9%, and 10%, respectively. Because these metabolite findings did not meet a Bonferroni threshold for 1400 tests, they are interpreted as exploratory candidate mediators. Genetically predicted ZDHHC8 expression is associated with osteoporosis risk across complementary genetic and expression analyses. The metabolite results suggest possible intermediate pathways but remain hypothesis-generating. These findings support further functional study of ZDHHC8 in bone cells rather than immediate clinical targeting.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050859","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:01:56Z","timestamp":1790359316000},"page":"e50859","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Genetically predicted ZDHHC8 expression and osteoporosis risk"],"prefix":"10.1097","volume":"105","author":[{"given":"Wenli","family":"Yang","sequence":"first","affiliation":[{"name":"Health Management Department, Luzhou People\u2019s Hospital, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Yang","sequence":"additional","affiliation":[{"name":"Health Management Department, Luzhou People\u2019s Hospital, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangyi","family":"Xu","sequence":"additional","affiliation":[{"name":"Health Management Department, Luzhou People\u2019s Hospital, Luzhou, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3998-1563","authenticated-orcid":false,"given":"Shuang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital of Chongqing College of Chinese Medicine, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women.","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"159","DOI":"10.11622\/smedj.2021036","article-title":"Menopausal osteoporosis: screening, prevention and treatment.","volume":"62","author":"Yong","year":"2021","journal-title":"Singapore Med J"},{"key":"R3-20261104","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine.","volume":"29","author":"Wright","year":"2014","journal-title":"J Bone Miner Res"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ecl.2012.04.006","article-title":"Pathophysiology of osteoporosis: new mechanistic insights.","volume":"41","author":"Armas","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R5-20261104","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/prd.12422","article-title":"Osteoporosis and periodontal diseases - An update on their association and mechanistic links.","volume":"89","author":"Yu","year":"2022","journal-title":"Periodontol 2000"},{"key":"R6-20261104","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/cells12182209","article-title":"Diverse roles of protein palmitoylation in cancer progression, immunity, stemness, and beyond.","volume":"12","author":"Li","year":"2023","journal-title":"Cells"},{"key":"R7-20261104","doi-asserted-by":"crossref","first-page":"600368","DOI":"10.3389\/fcell.2020.600368","article-title":"Protein palmitoylation in leukocyte signaling and function.","volume":"8","author":"Yang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R8-20261104","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41580-024-00700-8","article-title":"Mechanisms and functions of protein S-acylation.","volume":"25","author":"Mesquita","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R9-20261104","first-page":"101675","article-title":"Palmitoylation in cardiovascular diseases: molecular mechanism and therapeutic potential.","volume":"58","author":"Wang","year":"2025","journal-title":"Int J Cardiol Heart Vasc"},{"key":"R10-20261104","doi-asserted-by":"crossref","first-page":"1547636","DOI":"10.3389\/fonc.2025.1547636","article-title":"Advances in targeting protein S-palmitoylation in tumor immunity and therapy.","volume":"15","author":"Han","year":"2025","journal-title":"Front Oncol"},{"key":"R11-20261104","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fcell.2019.00281","article-title":"More favorable palmitic acid over palmitoleic acid modification of Wnt3 ensures its localization and activity in plasma membrane domains.","volume":"7","author":"Azbazdar","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"R12-20261104","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41586-022-04952-2","article-title":"Mechanisms and inhibition of Porcupine-mediated Wnt acylation.","volume":"607","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"R13-20261104","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41421-024-00689-6","article-title":"Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis.","volume":"10","author":"Zhu","year":"2024","journal-title":"Cell Discov"},{"key":"R14-20261104","doi-asserted-by":"crossref","first-page":"e4135","DOI":"10.1371\/journal.pone.0004135","article-title":"Protein palmitoylation regulates osteoblast differentiation through BMP-induced osterix expression.","volume":"4","author":"Leong","year":"2009","journal-title":"PLoS ONE"},{"key":"R15-20261104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jot.2023.06.002","article-title":"Pharmacological inhibition of protein S-palmitoylation suppresses osteoclastogenesis and ameliorates ovariectomy-induced bone loss.","volume":"42","author":"Ma","year":"2023","journal-title":"J Orthop Translat"},{"key":"R16-20261104","doi-asserted-by":"crossref","first-page":"993253","DOI":"10.3389\/fendo.2022.993253","article-title":"Application of metabolomics in osteoporosis research.","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R17-20261104","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11914-023-00785-8","article-title":"Metabolomics of osteoporosis in humans: a systematic review.","volume":"21","author":"Lau","year":"2023","journal-title":"Curr Osteoporos Rep"},{"key":"R18-20261104","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jbmr.3358","article-title":"Metabolomic pathways to osteoporosis in middle-aged women: a genome-metabolome-wide mendelian randomization study.","volume":"33","author":"Moayyeri","year":"2018","journal-title":"J Bone Miner Res"},{"key":"R19-20261104","first-page":"a041302","article-title":"Mendelian randomization.","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R20-20261104","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR Statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R21-20261104","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression.","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat Genet"},{"key":"R22-20261104","doi-asserted-by":"crossref","first-page":"1337478","DOI":"10.3389\/fimmu.2024.1337478","article-title":"Protein S-palmitoylation modification: implications in tumor and tumor immune microenvironment.","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"R23-20261104","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1152\/physrev.00032.2014","article-title":"The physiology of protein S-acylation.","volume":"95","author":"Chamberlain","year":"2015","journal-title":"Physiol Rev"},{"key":"R24-20261104","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"R25-20261104","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R26-20261104","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R27-20261104","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets.","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet"},{"key":"R28-20261104","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation.","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"R29-20261104","doi-asserted-by":"crossref","first-page":"216619","DOI":"10.1016\/j.canlet.2024.216619","article-title":"AMPK\u03b11-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma.","volume":"584","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"key":"R30-20261104","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s43018-025-00937-y","article-title":"Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity.","volume":"6","author":"Zhou","year":"2025","journal-title":"Nat Cancer"},{"key":"R31-20261104","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41467-025-56344-5","article-title":"Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis.","volume":"16","author":"Huang","year":"2025","journal-title":"Nat Commun"},{"key":"R32-20261104","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death.","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"R33-20261104","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4.","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"R34-20261104","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.freeradbiomed.2024.08.014","article-title":"7,8-DHF inhibits BMSC oxidative stress via the TRKB\/PI3K\/AKT\/NRF2 pathway to improve symptoms of postmenopausal osteoporosis.","volume":"223","author":"Li","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"R35-20261104","doi-asserted-by":"crossref","first-page":"9067610","DOI":"10.1155\/2020\/9067610","article-title":"Melatonin suppresses ferroptosis induced by high glucose via activation of the Nrf2\/HO-1 signaling pathway in Type 2 diabetic osteoporosis.","volume":"2020","author":"Ma","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R36-20261104","doi-asserted-by":"crossref","first-page":"111598","DOI":"10.1016\/j.cellsig.2025.111598","article-title":"Mechanisms of Ferroptosis in bone disease: a new target for osteoporosis treatment.","volume":"127","author":"Wang","year":"2025","journal-title":"Cell Signal"},{"key":"R37-20261104","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/10985549.2024.2443138","article-title":"acp\u00b3U: a conserved RNA modification with lessons yet to unfold.","volume":"45","author":"Mandler","year":"2025","journal-title":"Mol Cell Biol"},{"key":"R38-20261104","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1261\/rna.080004.124","article-title":"The modification landscape of Pseudomonas aeruginosa tRNAs.","volume":"30","author":"Mandler","year":"2024","journal-title":"RNA"},{"key":"R39-20261104","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1038\/s41467-019-13525-3","article-title":"Biogenesis and functions of aminocarboxypropyluridine in tRNA.","volume":"10","author":"Takakura","year":"2019","journal-title":"Nat Commun"},{"key":"R40-20261104","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1136\/gutjnl-2020-323314","article-title":"Human and preclinical studies of the host-gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health.","volume":"70","author":"Brial","year":"2021","journal-title":"Gut"},{"key":"R41-20261104","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis.","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:02:32Z","timestamp":1793804552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050859"}},"subtitle":["A two-sample Mendelian randomization and metabolite mediation study"],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":41,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050859","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"2026-03-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}